PAR PHARMACEUTICAL COMPANIES, INC. (PRX) has 42 open-market insider trades by 17 insiders since 2006. The most active filer is Paul Campanelli, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Capital Lp Deerfield | 10% | — | 2 | $21.6M | 2007-02-01 |
| Paul Campanelli | CEO | — | 6 | $6.5M | 2012-09-28 |
| Thomas Haughey | Pres | — | 6 | $6.4M | 2012-09-28 |
| International Ltd Deerfield | 10% | — | 2 | $6.1M | 2009-08-18 |
| Arie Gutman | — | — | 3 | $5.0M | 2006-01-31 |
| Patrick G. Lepore | Chairman | — | 4 | $2.8M | 2012-09-28 |
| John A. MacPhee | EVPPres-Strativa | — | 4 | $1.2M | 2011-01-11 |
| Joseph E. Smith | Dir | — | 1 | $923K | 2012-09-28 |
| Melvin Sharoky M.D. | Dir | — | 2 | $895K | 2010-04-15 |
| Lawrence A. Kenyon | — | — | 1 | $533K | 2010-08-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Ronald M. Nordmann | Director | Sell | $278K | 2012-03-19 |
| Peter S. Knight | Director | Sell | $278K | 2012-03-19 |
| Ronald M. Nordmann | Director | Sell | $81K | 2011-12-15 |
| Peter S. Knight | Director | Sell | $81K | 2011-12-15 |
| Michael A. Tropiano | EVP & CFO | Buy | $55K | 2011-09-06 |
| Patrick G. Lepore | Chairman & President | Buy | $207K |
Companies that share insiders with PRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2011-09-06 |
| Thomas Haughey | CAO & EVP +1 | Sell | $953K | 2011-05-10 |
| Thomas Haughey | CAO & EVP +1 | Sell | $3.7M | 2011-05-09 |
| Patrick G. Lepore | Chairman & President | Sell | $2.2M | 2011-05-09 |
| Paul Campanelli | EVP & Pres-Par Pharmaceutical | Sell | $1.5M | 2011-03-08 |
| Paul Campanelli | EVP & Pres-Par Pharmaceutical | Sell | $466K | 2011-03-07 |
| Paul Campanelli | EVP & Pres-Par Pharmaceutical | Sell | $3.2M | 2011-03-07 |
| Melvin Sharoky M.D. | Director | Sell | $549K | 2010-04-15 |
| John A. MacPhee | EVP & Pres-Strativa | Sell | $998K | 2010-03-09 |
| John A. MacPhee | EVP & Pres-Strativa | Sell | $81K | 2010-03-09 |